Mizied Falah
Chief Tech/Sci/R&D Officer at VESSL Therapeutics Ltd.
Profile
Mizied Falah was the founder of GeneArrest Ltd., a company founded in 2009, where he held the title of Chief Technology Officer.
He is currently working at VESSL Therapeutics Ltd.
as the Director of Strategic Research & Development since 2013.
Dr. Falah obtained a doctorate degree from McMaster University in 1997 and completed undergraduate and graduate studies at The Hebrew University of Jerusalem.
Mizied Falah active positions
| Companies | Position | Start |
|---|---|---|
VESSL Therapeutics Ltd.
 VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Chief Tech/Sci/R&D Officer | - |
Former positions of Mizied Falah
| Companies | Position | End |
|---|---|---|
GeneArrest Ltd.
 GeneArrest Ltd. Miscellaneous Commercial ServicesCommercial Services GeneArrest Ltd. develops drug discovery technology. Its antigene drug discovery platform is a route to capitalize on new insights in genomic information to make novel drugs. The company's technology is based on proprietary bioinformatics tools used to design selective and specific gene-silencing chemicals. GeneArrest was founded by Mizied Falah and Anwar Rayan in 2009 and is headquartered in Nazareth, Israel. | Founder | - |
Training of Mizied Falah
| McMaster University | Doctorate Degree |
| The Hebrew University of Jerusalem | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
VESSL Therapeutics Ltd.
VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Health Technology |
GeneArrest Ltd.
GeneArrest Ltd. Miscellaneous Commercial ServicesCommercial Services GeneArrest Ltd. develops drug discovery technology. Its antigene drug discovery platform is a route to capitalize on new insights in genomic information to make novel drugs. The company's technology is based on proprietary bioinformatics tools used to design selective and specific gene-silencing chemicals. GeneArrest was founded by Mizied Falah and Anwar Rayan in 2009 and is headquartered in Nazareth, Israel. | Commercial Services |
- Stock Market
- Insiders
- Mizied Falah
